For cases of carcinoma in situ or invasive disease CK20 was expressed in the upper 2/3 or full thickness of the urothelium in 19/26 (73%) of cases while p53 was moderate or heavy in 19/26 cases (73%). This evidence concerns the gene TP53 and in situ carcinoma.